tiprankstipranks
Trending News
More News >
SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX

SkinBioTherapeutics (SBTX) Revenue

Compare
21 Followers

SkinBioTherapeutics Revenue

SkinBioTherapeutics had a revenue of 3.06M in the quarter ending Jun 30, 2025, with 94.14%. This bring the company's revenue in the last twelve months to 4.64M, Decreased 73.15%. In the fiscal year ending Dec 31, 2024, SkinBioTherapeutics had annual revenue of 4.64M with 283.63% growth.
Revenue (ttm)
4.64M
Revenue Growth
283.74%
P/S Ratio
7.60
Revenue/Employee
£309,210
Employees
15
Market Cap
£35.26M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
4.64M3.43M+383.64%
Dec 31, 2023
1.21M1.08M+915.52%
Dec 31, 2022
132.06K57.30K+176.64%
Dec 31, 2021
74.76K-7,476,100.00%
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016